ARQTArcutis Biotherapeutics, Inc.
Is it growing?
Neither accelerating nor breaking down: revenue growing +76% year on year and operating margin widening (+45.0 points), but earnings down −128% year on year.
Trailing-twelve-month revenue vs a year earlier, from the company's own filings.
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Trailing-twelve-month operating margin, 6.7% now against -38.3% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is ARQT growing?
Arcutis Biotherapeutics, Inc. has grown revenue 367% a year over three years.
Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed
- Years of annual history on file
- 8
Years of annual history on file · FY2018 to FY2025, as filed
Details›
- Revenue FY2021
- $0
- Revenue FY2022
- $3.7M
- Revenue FY2023
- $60M
- Revenue FY2024
- $197M
- Revenue FY2025
- $376M
Annual income statements as filed with the SEC.